Hostname: page-component-7479d7b7d-68ccn Total loading time: 0 Render date: 2024-07-08T12:37:59.993Z Has data issue: false hasContentIssue false
  • English
  • Français

An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study

Published online by Cambridge University Press:  18 March 2020

Lisa M. Fucito Open the ORCID record for Lisa M. Fucito [Opens in a new window] ,
Ran Wu ,
Stephanie S. O'Malley ,
Tess H. Hanrahan ,
Jolomi T. Ikomi ,
Srinivas Muvvala ,
Kathleen M. Carroll  and
Ralitza Gueorguieva
Lisa M. Fucito*
Affiliation:
Department of Psychiatry, Yale School of Medicine, New Haven, USA Yale Cancer Centre, New Haven, USA Smilow Cancer Hospital at Yale-New Haven, New Haven, USA
Ran Wu
Affiliation:
Department of Psychiatry, Yale School of Medicine, New Haven, USA
Stephanie S. O'Malley
Affiliation:
Department of Psychiatry, Yale School of Medicine, New Haven, USA Yale Cancer Centre, New Haven, USA
Tess H. Hanrahan
Affiliation:
Department of Psychiatry, Yale School of Medicine, New Haven, USA
Jolomi T. Ikomi
Affiliation:
Department of Psychiatry, Yale School of Medicine, New Haven, USA
Srinivas Muvvala
Affiliation:
Department of Psychiatry, Yale School of Medicine, New Haven, USA
Kathleen M. Carroll
Affiliation:
Department of Psychiatry, Yale School of Medicine, New Haven, USA
Ralitza Gueorguieva
Affiliation:
Department of Psychiatry, Yale School of Medicine, New Haven, USA Yale School of Public Health, New Haven, USA
*
Author for correspondence: Lisa M. Fucito, E-mail: lisa.fucito@yale.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

Combined smoking and heavy drinking is a significant health burden. Varenicline, an efficacious tobacco pharmacotherapy that also shows promise for drinking, has yielded mixed results among heavy-drinking smokers. This pilot study investigated integrated tobacco and alcohol counselling plus varenicline for this vulnerable group.

Design

Twelve-week parallel, randomized controlled pilot trial of two behavioural interventions in combination with open-label varenicline. Participants were randomized using computer-generated tables, stratified by sex.

Setting

Outpatient academic medical centre research clinic.

Participants

Volunteers who reported smoking and heavy drinking and sought tobacco or alcohol treatment (N = 26).

Intervention

(1) Integrated tobacco + alcohol counselling (INT; n = 13) or (2) counselling focused on their presenting concern (i.e., tobacco or alcohol) (SINGLE; n = 13), plus varenicline (2 mg) for 12 weeks.

Main outcomes

Feasibility/acceptability, smoking quit rates and heavy drinking.

Results

INT feasibility/acceptability was high among men but not women. More participants quit smoking in INT than SINGLE. This outcome was only in men, not significant, but had a medium effect size. Both conditions yielded significant drinking reductions.

Conclusion

Integrated tobacco and alcohol behavioural counselling plus varenicline may be feasible and promote smoking cessation among men who smoke and drink heavily, but a larger sample is needed to replicate this finding.

Keywords

Alcoholbehavioural treatmentcigarette smokingheavy drinkingsmoking cessationvarenicline
Type
Original Articles
Information
Journal of Smoking Cessation , Volume 15 , Issue 3 , September 2020 , pp. 119 - 127
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abrams, D. B., Rohsenow, D. J., Niaura, R. S., Pedraza, M., Longabaugh, R., Beattie, M. C., … Monti, P. M. (1992). Smoking and treatment outcome for alcoholics – effects on coping skills, urge to drink, and drinking rates. Behavior Therapy, 23(2), 283–297. doi: 10.1016/S0005-7894(05)80386-7CrossRefGoogle Scholar
Agabio, R., Pisanu, C., Gessa, G. L., & Franconi, F. (2017). Sex differences in alcohol use disorder. Current Medicinal Chemistry, 24(24), 2661–2670. doi: 10.2174/0929867323666161202092908CrossRefGoogle ScholarPubMed
Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., … Evins, A. E. (2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): A double-blind, randomised, placebo-controlled clinical trial. Lancet (London, England), 387(10037), 2507–2520. doi: 10.1016/S0140-6736(16)30272-0CrossRefGoogle ScholarPubMed
Apollonio, D., Philipps, R., & Bero, L. (2016). Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database of Systematic Reviews, 11, CD010274. doi: 10.1002/14651858.CD010274.pub2Google ScholarPubMed
Bandura, A. (1998). Health promotion from the perspective of social cognitive theory. Psychology and Health, 13, 623–649.CrossRefGoogle Scholar
Bandura, A. (2004). Health promotion by social cognitive means. Health Education and Behavior, 31, 143–164.CrossRefGoogle ScholarPubMed
Biener, L., & Abrams, D. B. (1991). The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology, 10(5), 360–365.CrossRefGoogle ScholarPubMed
Cooney, N. L., Litt, M. D., Cooney, J. L., Pilkey, D. T., Steinberg, H. R., & Oncken, C. A. (2007a). Alcohol and tobacco cessation in alcohol-dependent smokers: Analysis of real-time reports. Psychology of Addictive Behaviors, 21(3), 277–286. doi: 10.1037/0893-164X.21.3.277CrossRefGoogle Scholar
Cooney, N. L., Litt, M. D., Cooney, J. L., Pilkey, D. T., Steinberg, H. R., & Oncken, C. A. (2007b). Concurrent brief versus intensive smoking intervention during alcohol dependence treatment. Psychology of Addictive Behaviors, 21(4), 570–575. doi: 10.1037/0893-164X.21.4.570CrossRefGoogle Scholar
Cooney, N. L., Litt, M. D., Sevarino, K. A., Levy, L., Kranitz, L. S., Sackler, H., & Cooney, J. L. (2015). Concurrent alcohol and tobacco treatment: Effect on daily process measures of alcohol relapse risk. Journal of Consulting and Clinical Psychology, 83(2), 346–358. doi: 10.1037/a0038633CrossRefGoogle ScholarPubMed
Crits-Christoph, P., & Mintz, J. (1991). Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. Journal of Consulting and Clinical Psychology, 59(1), 20–26.CrossRefGoogle ScholarPubMed
Dawson, D. A. (2000). Drinking as a risk factor for sustained smoking. Drug and Alcohol Dependence, 59(3), 235–249.CrossRefGoogle ScholarPubMed
de Bejczy, A., Lof, E., Walther, L., Guterstam, J., Hammarberg, A., Asanovska, G., … Soderpalm, B. (2015). Varenicline for treatment of alcohol dependence: A randomized, placebo-controlled trial. Alcoholism: Clinical and Experimental Research, 39(11), 2189–2199. doi: 10.1111/acer.12854CrossRefGoogle ScholarPubMed
Edlund, M. J., Booth, B. M., & Feldman, Z. L. (2009). Perceived need for treatment for alcohol use disorders: Results from two national surveys. Psychiatric Services, 60(12), 1618–1628. doi: 10.1176/ps.2009.60.12.1618CrossRefGoogle ScholarPubMed
Falk, D. E., Yi, H. Y., & Hiller-Sturmhofel, S. (2006). An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Research & Health, 29(3), 162–171.Google ScholarPubMed
Feduccia, A. A., Simms, J. A., Mill, D., Yi, H. Y., & Bartlett, S. E. (2014). Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens. British Journal of Pharmacology, 171(14), 3420–3431. doi: 10.1111/bph.12690CrossRefGoogle ScholarPubMed
Fiore, M., Jaen, C., Baker, T., Bailey, W. C., Benowitz, N., Curry, S. J., … Wewers, M. E. (2008). Treating tobacco use and dependence, 2008 update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service.Google Scholar
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/PSY SCREEN). NY: Biometrics Research, New York State Psychiatric Institute.Google Scholar
Fucito, L. M., Park, A., Gulliver, S. B., Mattson, M. E., Gueorguieva, R. V., & O'Malley, S. S. (2012). Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence. Biological Psychiatry, 72(10), 832–838. doi: 10.1016/j.biopsych.2012.03.023CrossRefGoogle ScholarPubMed
Fucito, L. M., Toll, B. A., Wu, R., Romano, D. M., Tek, E., & O'Malley, S. S. (2011). A preliminary investigation of varenicline for heavy drinking smokers. Psychopharmacology (Berl), 215(4), 655–663. doi: 10.1007/s00213-010-2160-9CrossRefGoogle ScholarPubMed
Gonzales, D., Rennard, S. I., Nides, M., Oncken, C., Azoulay, S., Billing, C. B., … Varenicline Phase 3 Study Group (2006). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA, 296(1), 47–55. doi: 10.1001/jama.296.1.47CrossRefGoogle ScholarPubMed
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., … Hasin, D. S. (2015). Epidemiology of DSM-5 alcohol use disorder: Results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiatry, 72(8), 757–766. doi: 10.1001/jamapsychiatry.2015.0584CrossRefGoogle ScholarPubMed
Gueorguieva, R. (2017). Statistical methods in psychiatry and related fields: Longitudinal, clustered and other repeated measures data. Chapman & Hall/CRC Interdisciplinary Statistics series. Abingdon, England: Taylor and Francis, LLC.Google Scholar
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction, 86(9), 1119–1127.CrossRefGoogle ScholarPubMed
Hurt, R. T., Ebbert, J. O., Croghan, I. T., Schroeder, D. R., Hurt, R. D., & Hay, J. T. (2018). Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial. Drug and Alcohol Dependence, 184, 12–17.CrossRefGoogle ScholarPubMed
Jorenby, D. E., Hays, J. T., Rigotti, N. A., Azoulay, S., Watsky, E. J., & Williams, K. E., … Varenicline Phase 3 Study Group (2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. JAMA, 296(1), 56–63. doi: 10.1001/jama.296.1.56CrossRefGoogle ScholarPubMed
Kadden, R. M., Carroll, K. M., Donovan, D. M., Cooney, N. L., Monti, P. M., Abrams, D. B., … Hester, R. (1992, 1995 revision). Cognitive-Behavioral Coping Skills Therapy Manual. A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Project Match Monograph 3, Reprinted NIH Pub. No. 94-3724. Rockville, MD: National Institute on Alcoholism and Alcohol Abuse.Google Scholar
Kahler, C. W., Cioe, P. A., Tzilos, G. K., Spillane, N. S., Leggio, L., Ramsey, S. E., … O'Malley, S. S. (2017). Double-blind randomized placebo-controlled trial of oral naltrexone for heavy-drinking smokers seeking smoking cessation treatment. Alcoholism: Clinical and Experimental Research, 41, 1201–1211.CrossRefGoogle ScholarPubMed
Kahler, C. W., Metrik, J., LaChance, H. R., Ramsey, S. E., Abrams, D. B., Monti, P. M., & Brown, R. A. (2008). Addressing heavy drinking in smoking cessation treatment: A randomized clinical trial. Journal of Consulting and Clinical Psychology, 76(5), 852–862. doi: 10.1037/a0012717CrossRefGoogle ScholarPubMed
Kahler, C. W., Metrik, J., Spillane, N. S., Leventhal, A. M., McKee, S. A., Tidey, J. W., … Rohsenow, D. J. (2012). Sex differences in stimulus expectancy and pharmacologic effects of a moderate dose of alcohol on smoking lapse risk in a laboratory analogue study. Psychopharmacology, 222, 71–80.CrossRefGoogle Scholar
Kalman, D., Kim, S., DiGirolamo, G., Smelson, D., & Ziedonis, D. (2010). Addressing tobacco use disorder in smokers in early remission from alcohol dependence: The case for integrating smoking cessation services in substance use disorder treatment programs. Clinical Psychology Review, 30(1), 12–24. doi: 10.1016/j.cpr.2009.08.009CrossRefGoogle ScholarPubMed
Kamens, H. M., Andersen, J., & Picciotto, M. R. (2010). The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. Alcoholism: Clinical and Experimental Research, 34(12), 2053–2060. doi: 10.1111/j.1530-0277.2010.01301.xCrossRefGoogle ScholarPubMed
King, A. C., Bernardy, N. C., & Hauner, K. (2003). Stressful events, personality, and mood disturbance: Gender differences in alcoholics and problem drinkers. Addictive Behaviors, 28(1), 171–187.CrossRefGoogle ScholarPubMed
King, A. C., & Canada, S. A. (2004). Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. Journal of Substance Abuse Treatment, 26(3), 189–195. doi: 10.1016/S0740-5472(03)00210-1CrossRefGoogle Scholar
Ko, J. K., & Cho, C. H. (2000). Alcohol drinking and cigarette smoking: A ‘partner’ for gastric ulceration. Zhonghua Yi Xue Za Zhi (Taipei), 63(12), 845–854.Google ScholarPubMed
Kouri, E. M., McCarthy, E. M., Faust, A. H., & Lukas, S. E. (2004). Pretreatment with transdermal nicotine enhances some of ethanol's acute effects in men. Drug and Alcohol Dependence, 75(1), 55–65. doi: 10.1016/j.drugalcdep.2004.01.011CrossRefGoogle ScholarPubMed
Kraemer, H. C., Mintz, J., Noda, A., Tinklenberg, J., & Yesavage, J. A. (2006). Caution regarding the use of pilot studies to guide power calculations for study proposals. Archives of General Psychiatry, 63(5), 484–489. doi: 10.1001/archpsyc.63.5.484CrossRefGoogle ScholarPubMed
Kuper, H., Tzonou, A., Kaklamani, E., Hsieh, C. C., Lagiou, P., Adami, H. O., … Stuver, S. O. (2000). Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. International Journal of Cancer, 85(4), 498–502.3.0.CO;2-F>CrossRefGoogle ScholarPubMed
Leeman, R. F., McKee, S. A., Toll, B. A., Krishnan-Sarin, S., Cooney, J. L., Makuch, R. W., & O'Malley, S. S. (2008). Risk factors for treatment failure in smokers: Relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine & Tobacco Research, 10(12), 1793–1809. doi: 10.1080/14622200802443742CrossRefGoogle ScholarPubMed
Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., … NCIG Study Group (2013). A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. Journal of Addiction Medicine, 7(4), 277–286. doi: 10.1097/ADM.0b013e31829623f4CrossRefGoogle ScholarPubMed
McCaul, M. E., Svikis, D. S., & Moore, R. D. (2001). Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependence, 62(1), 9–17.CrossRefGoogle ScholarPubMed
McKee, S. A., Falba, T., O'Malley, S. S., Sindelar, J., & O'Connor, P. G. (2007). Smoking status as a clinical indicator for alcohol misuse in US adults. Archives of Internal Medicine, 167(7), 716–721. doi: 10.1001/archinte.167.7.716CrossRefGoogle ScholarPubMed
McKee, S. A., Harrison, E. L., O'Malley, S. S., Krishnan-Sarin, S., Shi, J., Tetrault, J. M., … Balchunas, E. (2009). Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biological Psychiatry, 66(2), 185–190. doi: 10.1016/j.biopsych.2009.01.029CrossRefGoogle ScholarPubMed
Mertens, J. R., & Weisner, C. M. (2000). Predictors of substance abuse treatment retention among women and men in an HMO. Alcoholism: Clinical and Experimental Research, 24(10), 1525–1533.CrossRefGoogle Scholar
Milligan, C. O., Nich, C., & Carroll, K. M. (2004). Ethnic differences in substance abuse treatment retention, compliance, and outcome from two clinical trials. Psychiatric Services, 55(2), 167–173. doi: 10.1176/appi.ps.55.2.167CrossRefGoogle ScholarPubMed
Mitchell, J. M., Teague, C. H., Kayser, A. S., Bartlett, S. E., & Fields, H. L. (2012). Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology (Berl), 223(3), 299–306. doi: 10.1007/s00213-012-2717-xCrossRefGoogle ScholarPubMed
Mokdad, A. H., Marks, J. S., Stroup, D. F., & Gerberding, J. L. (2004). Actual causes of death in the United States, 2000. JAMA, 291(10), 1238–1245. doi: 10.1001/jama.291.10.1238CrossRefGoogle ScholarPubMed
National Institute on Alcohol Abuse and Alcoholism (NIAAA). What is ‘at-risk’ or ‘heavy’ drinking? Rethinking Drinking: Alcohol and your health. Retrieved September 30, 2018, from https://www.rethinkingdrinking.niaaa.nih.gov/How-much-is-too-much/Is-your-drinking-pattern-risky/Whats-At-Risk-Or-Heavy-Drinking.aspxGoogle Scholar
Nides, M., Oncken, C., Gonzales, D., Rennard, S., Watsky, E. J., Anziano, R., & Reeves, K. R. (2006). Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Archives of Internal Medicine, 166(15), 1561–1568. doi: 10.1001/archinte.166.15.1561CrossRefGoogle ScholarPubMed
O'Malley, S. S., Zweben, A., Fucito, L. M., Wu, R., Piepmeier, M. E., Ockert, D. M., … Gueorguieva, R. (2017). Effect of varenicline combined with medical management on alcohol use disorder with comorbid cigarette smoking: A randomized clinical trial. JAMA Psychiatry, 75(2), 129–138. doi: 10.1001/jamapsychiatry.2017.3544.CrossRefGoogle Scholar
Pelucchi, C., Gallus, S., Garavello, W., Bosetti, C., & La Vecchia, C. (2008). Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. European Journal of Cancer Prevention, 17(4), 340–344. doi: 10.1097/CEJ.0b013e3282f75e91CrossRefGoogle ScholarPubMed
Perkins, K. A., Karelitz, J. L., & Jao, N. C. (2013). Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine and Tobacco Research, 15(5), 978–982. doi: 10.1093/ntr/nts205CrossRefGoogle ScholarPubMed
Perkins, K. A., Sexton, J. E., DiMarco, A., Grobe, J. E., Scierka, A., & Stiller, R. L. (1995). Subjective and cardiovascular responses to nicotine combined with alcohol in male and female smokers. Psychopharmacology (Berl), 119(2), 205–212.CrossRefGoogle ScholarPubMed
Piasecki, T. M., Jahng, S., Wood, P. K., Robertson, B. M., Epler, A. J., Cronk, N. J., … Sher, K. J. (2011). The subjective effects of alcohol-tobacco co-use: An ecological momentary assessment investigation. Journal of Abnormal Psychology, 120(3), 557–571. doi: 10.1037/a0023033CrossRefGoogle ScholarPubMed
Piasecki, T. M., McCarthy, D. E., Fiore, M. C., & Baker, T. B. (2008). Alcohol consumption, smoking urge, and the reinforcing effects of cigarettes: An ecological study. Psychology of Addictive Behaviors, 22(2), 230–239. doi: 10.1037/0893-164X.22.2.230CrossRefGoogle Scholar
Prabhu, A., Obi, K. O., & Rubenstein, J. H. (2014). The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: A meta-analysis. American Journal of Gastroenterology, 109(6), 822–827. doi: 10.1038/ajg.2014.71CrossRefGoogle ScholarPubMed
Prochaska, J. J., Delucchi, K., & Hall, S. M. (2004). A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology, 72(6), 1144–1156. doi: 10.1037/0022-006X.72.6.1144CrossRefGoogle ScholarPubMed
Pronk, N. P., Anderson, L. H., Crain, A. L., Martinson, B. C., O'Connor, P. J., Sherwood, N. E., & Whitebird, R. R. (2004). Meeting recommendations for multiple healthy lifestyle factors. Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members. American Journal of Preventive Medicine, 27(Suppl 2), 25–33. doi: 10.1016/j.amepre.2004.04.022CrossRefGoogle ScholarPubMed
Pronk, N. P., Peek, C. J., & Goldstein, M. G. (2004). Addressing multiple behavioral risk factors in primary care. A synthesis of current knowledge and stakeholder dialogue sessions. American Journal of Preventive Medicine, 27(Suppl 2), 4–17. doi: 10.1016/j.amepre.2004.04.024CrossRefGoogle ScholarPubMed
Ralevski, E., Perry, E. B. Jr., D'Souza, D. C., Bufis, V., Elander, J., Limoncelli, D., … Petrakis, I. (2012). Preliminary findings on the interactive effects of IV ethanol and IV nicotine on human behavior and cognition: A laboratory study. Nicotine & Tobacco Research, 14(5), 596–606. doi: 10.1093/ntr/ntr258CrossRefGoogle ScholarPubMed
Robinson, S. M., Sobell, L. C., Sobell, M. B., & Leo, G. I. (2014). Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychology of Addictive Behaviors, 28(1), 154–162. doi: 10.1037/a0030992CrossRefGoogle ScholarPubMed
Roche, D. J., Ray, L. A., Yardley, M. M., & King, A. C. (2016). Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers. Current Addiction Reports, 3(1), 125–137. doi: 10.1007/s40429-016-0081-3CrossRefGoogle ScholarPubMed
Rounsaville, B., Carroll, K., & Onken, L. (2001). A stage model of behavioral therapies research: Getting started and moving on from stage 1. Clinical Psychology: Science and Practice, 8, 133–142.Google Scholar
Saunders, S. M., Zygowicz, K. M., & D'Angelo, B. R. (2006). Person-related and treatment-related barriers to alcohol treatment. Journal of Substance Abuse Treatment, 30(3), 261–270. doi: 10.1016/j.jsat.2006.01.003CrossRefGoogle ScholarPubMed
Smith, P. H., Bessette, A. J., Weinberger, A. H., Sheffer, C. E., & McKee, S. A. (2016). Sex/gender differences in smoking cessation: A review. Preventive Medicine, 92, 135–140. doi: 10.1016/j.ypmed.2016.07.013CrossRefGoogle ScholarPubMed
Sobell, L. C., Agrawal, S., Sobell, M. B., Leo, G. I., Young, L. J., Cunningham, J. A., & Simco, E. R. (2003). Comparison of a quick drinking screen with the timeline followback for individuals with alcohol problems. Journal of Studies on Alcohol, 64(6), 858–861.CrossRefGoogle ScholarPubMed
Steensland, P., Simms, J. A., Holgate, J., Richards, J. K., & Bartlett, S. E. (2007). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proceeds of the National Academy of Sciences USA, 104(30), 12518–12523. doi: 10.1073/pnas.0705368104CrossRefGoogle ScholarPubMed
Sullivan, J. T., Sykora, K., Schneiderman, J., Naranjo, C. A., & Sellers, E. M. (1989). Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). British Journal of Addiction, 84(11), 1353–1357.CrossRefGoogle Scholar
Thurgood, S. L., McNeill, A., Clark-Carter, D., & Brose, L. S. (2016). A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery. Nicotine and Tobacco Research, 18(5), 993–1001. doi: 10.1093/ntr/ntv127CrossRefGoogle ScholarPubMed
Tiffany, S. T. (1995). Potential functions of classical conditioning in drug addiction. In Drummond, D. C., Tiffany, S. T., Glautier, S. & Remington, B. (Eds.), Addictive behavior: Cue exposure theory and practice (pp. 47–71). Hoboken, NJ: Wiley.Google Scholar
Toll, B. A., Martino, S., O'Malley, S. S., Fucito, L. M., McKee, S. A., Kahler, C. W., … Cummings, K. M. (2015). A randomized trial for hazardous drinking and smoking cessation for callers to a quitline. Journal of Consulting and Clinical Psychology, 83(3), 445–454. doi: 10.1037/a0038183CrossRefGoogle ScholarPubMed
Tucker, J. A., & Simpson, C. A. (2011). The recovery spectrum: From self-change to seeking treatment. Alcohol Research & Health, 33(4), 371–379.Google ScholarPubMed
Vakili, S., Sobell, L. C., Sobell, M. B., Simco, E. R., & Agrawal, S. (2008). Using the Timeline Followback to determine time windows representative of annual alcohol consumption with problem drinkers. Addictive Behaviors, 33(9), 1123–1130. doi: 10.1016/j.addbeh.2008.03.009CrossRefGoogle ScholarPubMed
Weiss, R. D., Griffin, M. L., Kolodziej, M. E., Greenfield, S. F., Najavits, L. M., Daley, D. C., … Hennen, J. A. (2007). A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. American Journal of Psychiatry, 164(1), 100–107.CrossRefGoogle ScholarPubMed
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005). Outcome criteria in smoking cessation trials: Proposal for a common standard. Addiction, 100(3), 299–303. doi: 10.1111/j.1360-0443.2004.00995.xCrossRefGoogle ScholarPubMed
Witkiewitz, K., Dearing, R. L., & Maisto, S. A. (2014). Alcohol use trajectories among non-treatment-seeking heavy drinkers. Journal of Studies on Alcohol and Drugs, 75(3), 415–422.CrossRefGoogle ScholarPubMed